| Literature DB >> 21389751 |
Daniel Chelliah1, Christian Mensah Sarfo-Poku, Baldassarre D Stea, Jennifer Gardetto, Jonathan Zumwalt.
Abstract
We present a report of a 12-year-old boy diagnosed with medulloblastoma at 22 months of age. A gross total resection was performed followed by adjuvant systemic chemotherapy due to his young age; however, the tumor recurred locally in the posterior fossa 7 months later. The recurrent tumor was excised and he received craniospinal radiation with a boost given to the posterior fossa followed by high-dose chemotherapy. He remained disease free for approximately 10 years without major neurologic deficit and only mild cognitive impairment. A routine follow-up MRI of the brain revealed an enhancing mass. The patient underwent surgical debulking and pathological examination revealed no residual immature medulloblastoma cells but instead mature ganglion cells, consistent with a gangliocytoma. The apparent maturation of primitive medulloblastoma cells is a rare phenomenon, which may have ensued from the long-term effects of adjuvant therapies inducing advanced cellular maturation.Entities:
Mesh:
Year: 2011 PMID: 21389751 DOI: 10.1159/000322896
Source DB: PubMed Journal: Pediatr Neurosurg ISSN: 1016-2291 Impact factor: 1.162